- Home
- OCGN vs NRC Comparison
OCGN vs NRC Comparison
Compare OCGN & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- NRC
- Stock Information
- Founded
- OCGN 2013
- NRC 1981
- Country
- OCGN United States
- NRC United States
- Employees
- OCGN N/A
- NRC N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- NRC Biotechnology: Commercial Physical & Biological Resarch
- Sector
- OCGN Health Care
- NRC Health Care
- Exchange
- OCGN Nasdaq
- NRC Nasdaq
- Market Cap
- OCGN 321.7M
- NRC 294.8M
- IPO Year
- OCGN N/A
- NRC N/A
- Fundamental
- Price
- OCGN $1.79
- NRC $11.92
- Analyst Decision
- OCGN Strong Buy
- NRC
- Analyst Count
- OCGN 3
- NRC 0
- Target Price
- OCGN $6.00
- NRC N/A
- AVG Volume (30 Days)
- OCGN 7.9M
- NRC 95.8K
- Earning Date
- OCGN 11-07-2025
- NRC 10-27-2025
- Dividend Yield
- OCGN N/A
- NRC 4.02%
- EPS Growth
- OCGN N/A
- NRC N/A
- EPS
- OCGN N/A
- NRC 0.77
- Revenue
- OCGN $4,754,000.00
- NRC $140,314,000.00
- Revenue This Year
- OCGN N/A
- NRC N/A
- Revenue Next Year
- OCGN N/A
- NRC N/A
- P/E Ratio
- OCGN N/A
- NRC $15.61
- Revenue Growth
- OCGN N/A
- NRC N/A
- 52 Week Low
- OCGN $0.52
- NRC $9.76
- 52 Week High
- OCGN $1.90
- NRC $21.64
- Technical
- Relative Strength Index (RSI)
- OCGN 70.01
- NRC 27.15
- Support Level
- OCGN $1.31
- NRC $11.82
- Resistance Level
- OCGN $1.85
- NRC $12.80
- Average True Range (ATR)
- OCGN 0.14
- NRC 0.59
- MACD
- OCGN 0.02
- NRC -0.23
- Stochastic Oscillator
- OCGN 78.81
- NRC 7.60
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.